3613 — Beijing Tong Ren Tang Chinese Medicine Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$7.70bn
- HK$5.61bn
- HK$1.52bn
- 87
- 57
- 12
- 52
Annual cashflow statement for Beijing Tong Ren Tang Chinese Medicine Co, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 689 | 686 | 778 | 826 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -25.4 | -14.4 | 6.6 | -7.91 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -192 | -633 | -77.8 | -346 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 551 | 116 | 777 | 547 | — |
| Capital Expenditures | -17 | -12.9 | -23.4 | -38.5 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 853 | 520 | -242 | 374 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 836 | 507 | -266 | 335 | — |
| Financing Cash Flow Items | -37.5 | -26.4 | -27.5 | -35.3 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -879 | -264 | -279 | -535 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 507 | 369 | 234 | 331 | — |